According to Nova one advisor, the global Intraoperative Imaging market value was estimated at US$ 2.1 Billion in 2020 and is projected to reach US$ 6.2 Billion by 2027, registering a CAGR of 6.3% from 2020 to 2027. The report contains 150+ pages with detailed analysis.
Overview of Intraoperative Imaging Market Study
Intraoperative Imaging market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.
Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4387
The global intraoperative imaging market offers significant growth potential for prominent as well as emerging product manufacturers. Technological advancements, rising incidence of surgeries and increased funding and public-private investments are some of the key factors driving the growth of the intraoperative imaging market.
Intraoperative Imaging Market Dynamics
Driver: Technological advancements in intraoperative imaging modalities
Over the past decade, the medical device sector has witnessed significant transformations and technological advancements in intraoperative imaging, including the emergence of focused imaging technologies and portable/handheld/smartphone-based intraoperative imaging devices. Technologically advanced intraoperative imaging systems offer faster results, higher image quality, easier operations, and simplified consoles as compared to traditional imaging devices.
The key players in the intraoperative imaging market are increasingly focusing on launching novel technologically advanced products. Innovation in this market focuses on developing economical, technologically advanced, and easy-to-use intraoperative imaging systems. An important technological advancement is a reduction in the noise/sound produced by intraoperative imaging systems. Key players have continually produced devices that produce far less sound. Such advancements focus on improving the functionality of intraoperative imaging systems and on expanding their application areas, thereby driving the demand for these systems among end users
Restraint: High cost of intraoperative imaging systems
Intraoperative imaging systems are priced at a premium and require high investments for installations, increasing the procedural cost for patients. This affects the adoption rate of new systems, especially in emerging countries; most healthcare facilities in these countries, consequently, cannot afford such systems.
Healthcare facilities that purchase such costly systems often depend on third-party payers (such as Medicare, Medicaid, or private health insurance plans) to reimburse costs incurred in screening and therapeutic procedures performed using these systems. As a result, factors such as continuous cuts in reimbursements for intraoperative imaging scans and the increasing cost of intraoperative imaging systems prevent medium-sized and small healthcare facilities from investing in advanced intraoperative imaging modalities.
Opportunity: High growth opportunities in emerging countries
Developing economies such as India, China, Brazil, South Korea, Turkey, Russia, and South Africa offer high growth opportunities for the major players in the intraoperative imaging market. Although the cost factor is a concern in these developing countries, their huge population base—especially in India and China—indicates a sustainable market for intraoperative imaging devices.
The higher incidence of chronic diseases such as cancer, stroke, and neUrological Surgery and cardiovascular diseases, as well as the higher death rates in these countries, showcase the need for early detection. For instance, GLOBOCAN 2020 data estimated that roughly over 50% of the global cancer population lived in developing regions. In addition, regulatory policies are more adaptive and business-friendly in the Asia Pacific than in western countries. Increasing competition in mature markets is expected to compel intraoperative imaging system manufacturers to focus on emerging markets.
Challenge: Hospital budget cuts
In response to increasing government pressure to reduce healthcare costs, several healthcare providers have aligned themselves with group purchasing organizations (GPOs), integrated health networks (IHNs), and integrated delivery networks (IDNs). These organizations aggregate their members’ purchases and bargain for a competitive price with the suppliers and manufacturers of medical devices. GPOs, IHNs, and IDNs negotiate heavily for the bulk purchases of intraoperative imaging devices. The rising cost of prescription drugs and a sharp decline in the proposed budget allocations for Health and Human Services in the US, as of 2019, have significantly reduced hospital budgets. A study by the American Hospital Association estimated that federal payment cuts to hospitals would amount to USD 218 billion by 2027, forcing hospitals to allocate smaller budgets annually.
By product, mobile c arm segment is expected to have the largest market share during the forecast period
Mobile C-arms are medical imaging devices that comprise a generator, the X-ray source, and an image intensifier or flat-panel detector. The X-rays emitted by the generator penetrate the patient’s body and are then converted into visible images by the image intensifiers or detectors before being displayed on the monitor. The growing demand for mobile C-arms is mainly attributed to their broadening application horizons. For instance, C-arms are used for a wide range of applications, including cardiovascular surgeries, neurosurgeries, gastroenterology surgeries, orthopedics, traumatology, and urology disorders.
Neurosurgery is the largest application segment of the intraoperative imaging market
The growing demand for intraoperative imaging solutions in neurosurgery is mainly attributed to the increasing adoption of intraoperative imaging products among medical professionals, owing to its technological advancements and rising awareness of intraoperative techniques. For instance, C-arms with high resolution and penetration are essential in monitoring the positioning of screws, instruments, implants, and the injected cement. Furthermore, 3D imaging with navigation enhances treatment precision and enables the intraoperative evaluation of surgical procedures. The use of C-arms for neurosurgery, especially spinal surgeries, is expected to increase in the coming years on account of technological advancements that have made diagnosing and treating issues easier than before.
Hospitals & Diagnostic centers accounted for the largest share of the intraoperative imaging market, by end users, in 2020
Hospitals routinely conduct a wide range of surgical procedures, and most of these surgeries are performed in hospital in-patient settings. Growth in this segment is primarily attributed to the growing number of minimally invasive surgeries and electrosurgery procedures performed in hospitals and the adoption of robotic surgery. The adoption of intraoperative imaging instruments is higher in hospitals, owing to their higher purchasing power and larger volume of surgeries performed. The rising incidence of road accidents, fall-related injuries, and sports injuries has resulted in an increasing number of orthopedic surgeries performed in hospitals; by adding to the procedural volume, the growing incidence of ailments requiring surgical treatment supports the use of intraoperative imaging devices.
Buy Complete Assessment of Intraoperative Imaging market Now@ https://www.novaoneadvisor.com/report/checkout/4387
COVID-19 Impact on Intraoperative Imaging Sales
Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Intraoperative Imaging market.
Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Intraoperative Imaging market 2021 onwards. This trend will however continue through the course of the report’s assessment period
This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Intraoperative Imaging market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Some of the prominent players in the Intraoperative Imaging market include:
General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market. Other notable companies are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US)
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
- Mobile C Arm
- Laparoscopic probes
- Drop-in probes
- Other devices
- X Rays
- Intraoperative optical imaging
- Orthopedic & Trauma Surgery
- Spine Surgery
- Cardiovascular Surgery
- ENT Surgery
- Emergency & Trauma Surgery
- HPB surgery
- General Surgery
- Other Applications
By End Users
- Hospitals & Diagnostic Centers
- Ambulatory Surgical Centers and Clinics
- Research Laboratories & Academic Institutes
Browse Complete Table of Content@ https://www.novaoneadvisor.com/toc/intraoperative-imaging-market
Why Buy this Report?
The purpose of Nova one advisor’s Intraoperative Imaging market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4387
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Call: +1 9197 992 333